Categoría: News

The combined results of two independent groups of researchers represent major progress in the development of safer, more efficiently produced iPS (induced pluripotent stem) cells.

Plans are underway at The Anthony Nolan Trust Cord Blood Bank at Nottingham Trent University in England for a major processing and storage facility of cord blood.

Michael West, CEO of BioTime, Inc., schedules key stem cell licensing topics for conference call.

A controversial embryonic stem cell company in Massachusetts fights to survive as it struggles with increasing debt.

Sir Ian Wilmut and Dr. Shinya Yamanaka are among those honored at a glittering ceremony in Hong Kong for their pioneering work.

NeoStem CEO, Dr. Robin Smith, will speak about «medical tourism» at the 2008 World Stem Cell Summit.

In a visually dramatic graphical representation, Drs. Rudolf Jaenisch and Christopher Lengner describe and contrast the properties of embryonic stem cells and pluripotent cells derived from non-embryonic sources.

Scientists have transformed one type of adult cell into another type, without the use of stem cells.

Researchers at Stanford University have once again confirmed problems with immune rejection that are inherent in embryonic stem cells.

Two major biotech companies in the stem cell industry sign yet another licensing agreement.